➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Medtronic
Baxter
AstraZeneca
Colorcon

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

ETOMIDATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Etomidate, and what generic alternatives are available?

Etomidate is a drug marketed by Aurobindo Pharma Ltd, Caplin, Emcure Pharms Ltd, Gland Pharma Ltd, Hikma, Luitpold, Mylan Labs Ltd, Par Sterile Products, West-ward Pharms Int, and Zydus Pharms. and is included in eleven NDAs.

The generic ingredient in ETOMIDATE is etomidate. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the etomidate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Etomidate

A generic version of ETOMIDATE was approved as etomidate by WEST-WARD PHARMS INT on November 4th, 1996.

  Get Started for $10

Drug patent expirations by year for ETOMIDATE
Drug Prices for ETOMIDATE

See drug prices for ETOMIDATE

Recent Clinical Trials for ETOMIDATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of BernPhase 4
The Cleveland ClinicPhase 3
Fourth Military Medical UniversityN/A

See all ETOMIDATE clinical trials

Pharmacology for ETOMIDATE
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for ETOMIDATE

US Patents and Regulatory Information for ETOMIDATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ETOMIDATE etomidate INJECTABLE;INJECTION 206126-001 Feb 24, 2017 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan Labs Ltd ETOMIDATE etomidate INJECTABLE;INJECTION 078289-001 Jan 2, 2009 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Gland Pharma Ltd ETOMIDATE etomidate INJECTABLE;INJECTION 209058-001 Apr 18, 2017 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan Labs Ltd ETOMIDATE etomidate INJECTABLE;INJECTION 201044-001 Feb 7, 2017 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Caplin ETOMIDATE etomidate INJECTABLE;INJECTION 215028-001 Dec 18, 2020 AP RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Moodys
Medtronic
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.